JESSICA COLE: Open Payments
NPI 1316185861 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 24 payments from 14 companies in 2025. Trend: 2023 $208 · 2024 $371 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $184 |
| CooperSurgical, Inc. | 1 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Biogen, Inc. | 1 | $28 |
| Dexcom, Inc. | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $24 |
| MILLICENT US INC | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $17 |
| Kerecis Limited | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: Veozah, Paragard T 380A, Mirena, ZURZUVAE, Lynkuet, Dexcom G6 Transmitter, INTRAROSA, ACESSA PROVU SYSTEM.
Industry payments across IN — which companies pay providers there.
